clinical trial · NCT07391605
Descartes-08 in Autoantibody Myositis
Antisynthetase SyndromeDescartes-08Placebo
brief summary
This is a randomized, double-blind, placebo-controlled phase 2 study to evaluate the efficacy, safety and tolerability of an autologous T-cells expressing a chimeric antigen receptor (CAR) directed to B-Cell maturation antigen (BCMA) in patients with autoantibody-mediated myositis, including antisynthetase syndrome (ASyS) and dermatomyositis (DM).
started
Apr 28, 2026
primary completion
Nov 1, 2027
completion
May 1, 2028
last updated
Apr 23, 2026
official title
A Randomized Double-Blind Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of Descartes-08 in Patients With Dermatomyositis and Antisynthetase Syndrome
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol